Misplaced Pages

Iovance Biotherapeutics

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
American biopharmaceutical startup
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Iovance Biotherapeutics" – news · newspapers · books · scholar · JSTOR (November 2019) (Learn how and when to remove this message)
Iovance Biotherapeutics, Inc.
FormerlyLion Biotechnologies, Inc.
Company typePublic
Traded as
Industry
Founded2007; 18 years ago (2007)
HeadquartersSan Carlos, California, U.S.
Key peopleSteven Rosenberg
Number of employees319 (December 31, 2021)
Websiteiovance.com

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.

History

The company was founded in 2007 as Genesis Biopharma. In 2013, Lion merged with Genesis Biopharma аnd became lion bio Pharma, then rebranded to Iovance in 2017.

In 2024 the US FDA gave accelerated approval to Lifileucel, the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma.

See also

References

  1. Garber, Ken (7 August 2019). "Pursuit of tumor-infiltrating lymphocyte immunotherapy speeds up". Nature Biotechnology. Retrieved 14 August 2019.
  2. Adelman, Jacob (29 May 2019). "New Navy Yard lab and office complex planned for Calif. cell-therapy research firm Iovance". The Philadelphia Inquirer. Retrieved 14 August 2019.
  3. "Genesis Biopharma Announces Completion of Merger with Lion Biotechnologies". www.businesswire.com. 2013-07-25. Retrieved 2020-01-17.
  4. Mullard, Asher (2024-02-19). "FDA approves first tumour-infiltrating lymphocyte (TIL) therapy, bolstering hopes for cell therapies in solid cancers". Nature Reviews Drug Discovery. doi:10.1038/d41573-024-00035-1. PMID 38374249.

External links

Stub icon

This United States corporation or company article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Misplaced Pages by expanding it.

Categories: